Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial

AI Briefing

• – Bluejay Diagnostics announces completion of pivotal clinical trial with 624 patient enrollments.
• – The SYMON-II Trial evaluates the company's SymphonyTM platform for IL-6 testing in critical care settings.
• – The trial aims to determine patient acuity for sepsis triage and monitoring.